Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023

A. Esmail; J. Xu; E. Burns; K. Gee; C. Wiechmann; Y. Zhang; R. Kieser; Z. Gong; G. Umoru; S. Shah; K. Sun; K. Heyne; M. Abdelrahim

doi:10.1016/j.annonc.2023.04.465

Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023

A. Esmail, J. Xu, E. Burns, K. Gee, C. Wiechmann, Y. Zhang, R. Kieser, Z. Gong, G. Umoru, S. Shah, K. Sun, K. Heyne, M. Abdelrahim

Research output: Contribution to journal › Conference article

Original language	English (US)
Pages (from-to)	S156
Journal	Annals of Oncology
Volume	34
Issue number	51
DOIs	https://doi.org/10.1016/j.annonc.2023.04.465 https://doi.org/10.1016/j.annonc.2023.04.465
State	Published - Jun 28 2023

Divisions

Infectious Disease
Medical Oncology

Access to Document

https://www.sciencedirect.com/science/article/pii/S0923753423006075

Cite this

Esmail, A., Xu, J., Burns, E., Gee, K., Wiechmann, C., Zhang, Y., Kieser, R., Gong, Z., Umoru, G., Shah, S., Sun, K., Heyne, K., & Abdelrahim, M. (2023). Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023. Annals of Oncology, 34(51), S156. https://doi.org/10.1016/j.annonc.2023.04.465, https://doi.org/10.1016/j.annonc.2023.04.465

Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023. / Esmail, A.; Xu, J.; Burns, E. et al.
In: Annals of Oncology, Vol. 34, No. 51, 28.06.2023, p. S156.

Research output: Contribution to journal › Conference article

Esmail, A , Xu, J, Burns, E, Gee, K, Wiechmann, C, Zhang, Y, Kieser, R, Gong, Z, Umoru, G, Shah, S , Sun, K , Heyne, K & Abdelrahim, M 2023, 'Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023', Annals of Oncology, vol. 34, no. 51, pp. S156. https://doi.org/10.1016/j.annonc.2023.04.465, https://doi.org/10.1016/j.annonc.2023.04.465

Esmail A , Xu J, Burns E, Gee K, Wiechmann C, Zhang Y et al. Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023. Annals of Oncology. 2023 Jun 28;34(51):S156. doi: 10.1016/j.annonc.2023.04.465, 10.1016/j.annonc.2023.04.465

@article{16c445f5349e49608ba69606e7848760,

title = "Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023",

author = "A. Esmail and J. Xu and E. Burns and K. Gee and C. Wiechmann and Y. Zhang and R. Kieser and Z. Gong and G. Umoru and S. Shah and K. Sun and K. Heyne and M. Abdelrahim",

note = "Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023",

year = "2023",

month = jun,

day = "28",

doi = "10.1016/j.annonc.2023.04.465",

language = "English (US)",

volume = "34",

pages = "S156",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "51",

}

TY - JOUR

T1 - Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab

T2 - P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023

AU - Esmail, A.

AU - Xu, J.

AU - Burns, E.

AU - Gee, K.

AU - Wiechmann, C.

AU - Zhang, Y.

AU - Kieser, R.

AU - Gong, Z.

AU - Umoru, G.

AU - Shah, S.

AU - Sun, K.

AU - Heyne, K.

AU - Abdelrahim, M.

N1 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023

PY - 2023/6/28

Y1 - 2023/6/28

U2 - 10.1016/j.annonc.2023.04.465

DO - 10.1016/j.annonc.2023.04.465

M3 - Conference article

SN - 0923-7534

VL - 34

SP - S156

JO - Annals of Oncology

JF - Annals of Oncology

IS - 51

ER -